disorders connected with cathecholaminergic system disturbances, in particular, schizophrenia, amphetamine challenge effects, drug abuse
Most patients experience no downtime or significant side effects, though minor bruising or discomfort at the injection site may occur
Long-term studies are limited, but short-term use (up to six months) has shown significant benefits
In SPMS, characterized by steady deterioration without acute attacks, treatment strategies often involve continuing or altering DMT used during the earlier RRMS phase, such as interferon beta, or considering immune-modulating agents, such as methotrexate, cyclophosphamide, or glucocorticoid pulses [142, 143]
Turkish J Med Sci (2017) 47(1):33442
TicinesiAMilaniCGuerraAAllegriFLauretaniFNouvenneAet alUnderstanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers